本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cue Biopharma, Inc.

26.76
+3.5815.44%
盤後26.760.00000.00%19:30 EDT
成交量:17.05萬
成交額:452.76萬
市值:1.94億
市盈率:-0.91
高:28.29
開:23.69
低:23.41
收:23.18
52周最高:45.50
52周最低:4.97
股本:726.44萬
流通股本:645.14萬
量比:0.94
換手率:2.64%
股息:- -
股息率:- -
每股收益(TTM):-29.4600
每股收益(LYR):-8.4244
淨資產收益率:-1603.48%
總資產收益率:-172.66%
市淨率:84.15
市盈率(LYR):-3.18

資料載入中...

2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/18

重要事件披露

8-K - Current report
2021/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals